Impact of COVID-19 on end-stage kidney disease incidence and clinical practice

참고문헌 (10)

1. Anand S, "Prevalence of SARSCoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA : a cross-sectional study", Lancet, 396, pp.1335~1344 (2020)
2. Robinson BM, "Worldwide early impact of COVID-19 on dialysis patients and staff and lessons learned : a DOPPS roundtable discussion", Kidney Med, 3, pp.619~634 (2021)
3. Park HC, "COVID-19-related clinical outcomes among Korean hemodialysis patients", Kidney Res Clin Pract, 41, pp.591~600 (2022)
4. "2023 USRDS annual data report: epidemiology of kidney disease in the United States" (2023)[URL]
5. "ERA annual reports" (2022)[URL]
6. "2024 KORDS registry: trends in epidemiologic characteristics of end-stage kidney disease from 2023 KORDS (Korean Renal Data System)" (2024)[URL]
7. Wetmore JB, "Changes in treatment of patients with incident ESKD during the novel coronavirus disease 2019 pandemic", J Am Soc Nephrol, 32, pp.2948~2957 (2021)
8. Kim AY, "Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic", Korean J Intern Med, 39, pp.967~978 (2024)
9. Sloan CE, "Trends in peritoneal dialysis use in the United States after medicare payment reform", Clin J Am Soc Nephrol, 14, pp.1763~1772 (2019)
10. Park HC, "Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019(COVID-19)in hemodialysis facilities", Kidney Res Clin Pract, 39, pp.145~150 (2020)

관련 논문AI추천